Clinical trial
MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis
NCT00301613 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- January 31, 2006
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
henoch-schoenlein purpura, nephritis